Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa882Source: DataRank Database

Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.35)OA: bronzeTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Guy Lloyd ORCID,Sanjeev Bhattacharyya ORCID,Richard P. Steeds ORCID,Kambiz Boomla,Jonathan P. Bestwick ORCID

Live enrichment

PubMed:33247916 PMC:PMC7823250 OpenAlex:https://openalex.org/W3109679691

National Institute for Health Research (NIHR)

Grant: CL-2016-19-001

National Institute for Health Research (NIHR)

National Institutes of Health

Department of Health

FWCI

2.35

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

journalhttps://academic.oup.com/jcem/article-pdf/106/2/e711/41847545/dgaa882.pdf

publisherhttps://academic.oup.com/jcem/article-pdf/106/2/e711/41847545/dgaa882.pdf

publisherhttp://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgaa882/35063704/dgaa882.pdf

journalhttps://doi.org/10.1210/clinem/dgaa882

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33247916

Fields of Study

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsGrowth Hormone and Insulin-like Growth FactorsAdultBiomarkersCabergolineCase-Control StudiesCohort StudiesEchocardiographyFemaleHeart Valve DiseasesHeart ValvesHumansHyperprolactinemiaIncidenceLondonMaleMiddle AgedPituitary NeoplasmsPrimary Health CareProlactinoma

MeSH Terms

CabergolineAdultEchocardiographyFemaleHeart Valve DiseasesHeart ValvesHumansHyperprolactinemiaLondonMaleMiddle AgedPituitary NeoplasmsPrimary Health CareProlactinomaCohort StudiesBiomarkersIncidenceCase-Control Studies

Keywords

CabergolineProlactinomaIncidence (geometry)MedicineClinical endpointPrimary careInternal medicineCardiologyRandomized controlled trialMathematicsProlactinPituitary adenomahyperprolactinemiaDopamine AgonistCardiac Valvulopathy

Sustainable Development Goals

SDG 0: Good health and well-being

Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints

FAIR Checklist

Authors (7)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)